Interventional procedure overview of alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension
Closed for comments This consultation ended on at Request commenting lead permission
References
Kandzari DE, Weber MA, Pathak A et al. (2024) Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial. Circulation.
Pathak A, Rudolph UM, Saxena M et al. (2023) Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. DOI: 10.4244/EIJ-D-23-00088
Mahfoud F, Renkin J, Sievert H et al. (2020) Alcohol-mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension. JACC. Cardiovascular interventions 13(4): 471-84
Mahfoud F, Sievert H, Bertog S et al. (2021) Long-term results up to 12 months after catheter-based alcohol-mediated renal denervation for treatment of resistant hypertension. Circulation: Cardiovascular Interventions: 918-26
Janas A, Krol M, Hochul M et al. (2020) Evaluation of transcatheter alcohol-mediated perivascular renal denervation to treat resistant hypertension. Journal of Clinical Medicine 9(6): 1-12
Fischell TA, Ebner A, Gallo S et al. (2016) Transcatheter alcohol-mediated perivascular renal denervation with the peregrine system: first-in-human experience. JACC. Cardiovascular interventions 9(6): 589-98
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions